The mis-regulation of signaling pathways in Alzheimer’s disease have serious impact on amyloid-β secretion, Tau phosphorylation, neurotransmitter signaling, glial function which eventually ameliorate the disease condition. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.